Scott Mendel, Chief Operating Officer at GenMark Diagnostics, Inc. (GNMK), sold 11,410 shares at $6.80 ($78K) on 2019-02-25, disclosed to the SEC on 2019-02-27.
Seasonal sale ($78k) by Chief Operating Officer — this insider has traded GNMK in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| GNMK | SELL | 2021-01-25 | $1.8M | — | Filing → |
| GNMK | SELL | 2021-01-21 | $727K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $137K | — | Filing → |